A practical guide for providers on helping patients find Dulera during the 2026 shortage, including availability tools, alternatives, and workflow tips.
The Dulera (Mometasone Furoate/Formoterol Fumarate) shortage has created a ripple effect in clinical practice. Patients are calling your office frustrated. Pharmacies are sending back prescriptions unfilled. And the lack of a generic alternative means there's no quick swap at the pharmacy counter.
As a provider, you're in a unique position to help your patients navigate this shortage efficiently. This guide provides a practical, step-by-step approach to managing Dulera access issues in your practice — from checking availability to switching therapies when necessary.
Dulera remains in limited supply as of early 2026. The shortage was first reported by Organon to the FDA in September 2025 and primarily affects:
Organon has not announced a firm resolution date. For the full shortage timeline and background, see our provider briefing on the Dulera shortage.
Understanding the root causes helps you communicate effectively with patients and set appropriate expectations:
Run a report in your EHR to identify all patients with active Dulera prescriptions. Reach out proactively rather than waiting for patients to call in distress. A simple message — "We're aware of the Dulera shortage and want to help you plan ahead" — can reduce patient anxiety and call volume.
Medfinder for Providers provides real-time pharmacy availability data for Dulera. Your front-desk or nursing staff can use this tool to:
This is the single most impactful workflow change you can make during the shortage. Instead of sending prescriptions blind and hoping for the best, you can confirm stock before the patient arrives at the pharmacy.
For patients who cannot locate Dulera, have alternative prescriptions ready to go. The most appropriate ICS/LABA alternatives include:
Approximate ICS dose conversions:
Many patients don't understand why their medication has suddenly become unavailable. Take 60 seconds to explain:
Consider sharing these patient-facing resources:
Patients switching from Dulera may face different cost structures on alternative agents. Proactively address this:
For a comprehensive cost guide, see our provider's guide to saving patients money on Dulera.
Here's a summary table for your clinical reference:
To minimize disruption from the shortage, consider these workflow adjustments:
The Dulera shortage is inconvenient, but with proactive planning and the right tools, you can ensure your patients maintain asthma control throughout. The key is getting ahead of the problem — identify affected patients, confirm availability before prescribing, and have alternatives ready.
Medfinder for Providers is your best tool for real-time stock checks. Use it, share it with your staff, and help your patients breathe easier — even when their usual medication is hard to find.
For the full clinical briefing on the shortage, including dose conversion guidance, see our Dulera shortage briefing for providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
